JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Axcelis
ACLS
$4.29B
| $14.4M | ﹤0.01% |
108,160
-729
| -0.7% | -$85.6K |
|
1877
TriNet
TNET
$3.14B
| $14.4M | ﹤0.01% |
178,780
-5,150
| -3% | -$403K |
|
1878
Vipshop
VIPS
$6.78B
| $14.4M | ﹤0.01% |
948,316
+815,299
| +613% | +$12.1M |
|
1879
Constellium
CSTM
$4.02B
| $14.4M | ﹤0.01% |
941,784
+76,952
| +9% | +$1.12M |
|
1880
Dolby
DLB
$5.84B
| $14.4M | ﹤0.01% |
167,998
+40,864
| +32% | +$3.3M |
|
1881
Information Services Group
III
$250M
| $14.3M | ﹤0.01% |
2,813,538
-105,967
| -4% | -$544K |
|
1882
PUT
Oracle
ORCL
$437B
| $14.3M | ﹤0.01% |
154,000
-49,900
| -24% | -$4.38M |
|
1883
CALL
Voya Financial
VOYA
$9.16B
| $14.3M | ﹤0.01% |
+200,000
| New | +$14M |
|
1884
PUT
Caterpillar
CAT
$395B
| $14.3M | ﹤0.01% |
62,400
-109,800
| -64% | -$26.5M |
|
1885
Descartes Systems
DSGX
$6.59B
| $14.2M | ﹤0.01% |
176,468
+27,295
| +18% | +$2.03M |
|
1886
Visteon
VC
$2.87B
| $14.2M | ﹤0.01% |
90,565
+16,377
| +22% | +$2.53M |
|
|
GRFS
1887
Grifois
GRFS
$5.38B
| $14.2M | ﹤0.01% |
1,923,501
+342,912
| +22% | +$2.97M |
|
|
SLY
1888
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $14.2M | ﹤0.01% |
168,595
+47,081
| +39% | +$4.08M |
|
1889
Community Health Systems
CYH
$424M
| $14.2M | ﹤0.01% |
2,887,785
+2,813,728
| +3,799% | +$14.8M |
|
1890
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $14.1M | ﹤0.01% |
226,277
-154,237
| -41% | -$9.48M |
|
1891
Rocket Pharmaceuticals
RCKT
$363M
| $14.1M | ﹤0.01% |
821,275
-26,046
| -3% | -$510K |
|
1892
Banco Bradesco
BBD
$33.7B
| $14.1M | ﹤0.01% |
5,363,625
-306,118
| -5% | -$814K |
|
1893
Sociedad Química y Minera de Chile
SQM
$21.1B
| $14M | ﹤0.01% |
172,724
+24,314
| +16% | +$2.09M |
|
1894
Pacific Biosciences
PACB
$361M
| $14M | ﹤0.01% |
1,208,876
+392,455
| +48% | +$3.9M |
|
1895
UiPath
PATH
$8.35B
| $14M | ﹤0.01% |
797,003
+446,751
| +128% | +$6.75M |
|
1896
Kohl's
KSS
$2.21B
| $14M | ﹤0.01% |
594,397
-1,546,981
| -72% | -$43.6M |
|
1897
New Mountain Finance
NMFC
$733M
| $14M | ﹤0.01% |
1,148,529
+28,871
| +3% | +$363K |
|
1898
Mattel
MAT
$4.29B
| $14M | ﹤0.01% |
759,075
+85,493
| +13% | +$1.59M |
|
1899
PUT
Nike
NKE
$60.6B
| $14M | ﹤0.01% |
113,800
-47,600
| -29% | -$5.85M |
|
1900
GXO Logistics
GXO
$5.55B
| $13.9M | ﹤0.01% |
276,331
-94,530
| -25% | -$4.7M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.